Clinical Trials in Ohio

Showing 7181-7200 of 15,929 trials

COMPLETEDNA32 miles

Wear Experience With Daily Contact Lenses Over a Long Day

NCT04535310

This study is evaluating the wear experience of a daily contact lens after 10, 12, 14, and 16 hours of lens wear.

Contact Lens

Ohio State University35 participantsStarted Oct 2020

Columbus, Ohio, United States

COMPLETEDPhase 1/232 miles

Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study

NCT03252522

This proposed research will use randomized control trial (RCT) methodology and compare micronutrients with placebo in 135 children with ADHD.

Attention Deficit Hyperactivity Disorder

Oregon Health and Science University135 participantsStarted Apr 2018

Columbus, Ohio, United States • Portland, Oregon, United States • Lethbridge, Alberta, Canada

COMPLETEDPhase 132 miles

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

NCT02830542

The study will involve administering a single dose of investigational drug or placebo in ascending dose cohorts. This study is designed to evaluate the safety and tolerability of investigational drug as well as the efficacy of investigational drug versus placebo in adults with primary (first episode) Clostridium difficile infection (CDI).

Clostridium Difficile Infection

Seres Therapeutics, Inc.96 participantsStarted Aug 2016

Athens, Alabama, United States • Fountain Valley, California, United States • La Mesa, California, United States +19 more locations

Wear Experience With Daily Contact Lenses Over a Long Day

Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Find Trials by Condition in Ohio

Sargramostim Use in COVID-19 to Recover Patient Health

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Androgen Reduction in Congenital Adrenal Hyperplasia

A Study of Modified Stem Cells in Stable Ischemic Stroke

Pembrolizumab Plus Y90 Radioembolization in HCC Subjects

Enhancing Care of the Aged and Dying in Prisons Ph II

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent Prophylaxis